NAVMEDCOMINST 6230.2 Flashcards Preview

ADVANCEMENT BIB > NAVMEDCOMINST 6230.2 > Flashcards

Flashcards in NAVMEDCOMINST 6230.2 Deck (13)
Loading flashcards...
1
Q

Individuals treated for malaria must wait ____ years from the date treatment was finished until they are eligible to donate blood.

A

3 years

2
Q

Individuals who were in malaria-risk areas and were required to take chemoprophylaxis because of a perceived risk of exposure must wait ____ years fro the time chemoprophylaxis was finished.

A

3 years

3
Q

Individuals who visited malaria-risk area and remained asymptomatic, but were not required to take chemoprophylaxis because of negligible risk of exposure must wait how many months to donate blood?

A

6 months

4
Q

True or False. All Navy, Marine Corps, and MSC personnel must have a documented g6pd test result on their health record

A

True

5
Q

Any person who is G-6-PD deficient has a risk of hemolysis associated with taking ______ for chemoprophylaxis.

A

Primaquine

6
Q

Report suspected or confirmed malaria cases in a _____ .

A

Disease Alert Report. A malaria DAR should include the patient’s itinerary during the previous 3 months and the types and duration of any chemoprophylaxis or treatment medication taken

7
Q

What are the vectors of malaria?

A

Anopheline mosquito

8
Q

What are the chemoprophylaxis for malaria?

A

Traditionally, chloroquine and primaquine has been effective. Due to resistance to chloroquine, regimen may require the use of pyrimethamine-sulfadoxine or doxycycline.

9
Q

Since patterns of resistance and drug requirements change frequently, Medical Department of fleet units must contact ______-

A

NAVENPVNTMEDU prior to deployment to malaria-risk areas

10
Q

What is the Wilson-Edeson Test

A

Screening test for the presence of chloroquine in the urine. It tests for overall compliance with taking choroquine. 15% false negative rate.

11
Q

The most important aspect of malaria treatment is suspecting this disease in the ________ diagnosis of the patient and beginning immediate treatment.

A

Differential

12
Q

The types of parenteral antimalarial drugs used to treat severe cases of malaria are:

A

Parenteral chloroquine hydrochloride, quidine gluconate, and quinine dihydrochloride

13
Q

NAVMEDCOMINST 6230.2 is Malaria prevention and Control

A

End

Decks in ADVANCEMENT BIB Class (64):